XNYS · NUS
-2.06% · -$0.1100 · Vol 448.8K
After hours · updated 16:10:00 ET
NuSkin Enterprises, Inc.

NuSkin Enterprises, Inc.

WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
$5.22
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
NUS
NuSkin Enterprises, Inc.
Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

61/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 5/6 factors with data · Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is NUS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading NUS catalysts
About NuSkin Enterprises, Inc.
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Listed since
1996
Employees
9K
Country
US

Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$5.27
Day high
$5.29
Day low
$5.11
Previous close
$5.33
52W high
$12.84
-59.35% from high
52W low
$4.94
4% of range
Market cap
$258.8M
P/E
1.77×
EPS
$2.95
Beta
0.52
Shares out
48.6M
Volume
448.8K
0.70× rel vol
Avg volume
644.2K
VWAP
$5.21
Price history computed in-house
1W
-1.32%
1M
+3.57%
3M
-25.64%
1Y
-37.41%
YTD
-45.74%
SMA 50 $5.28 · below
SMA 200 $8.04 · below
52W position 4%

NUS overview

Loading financial statements
Loading NUS Form 4 filings
Public disclosures

Congress activity in NUS

No receipt-qualified Congressional disclosure is present for NUS in the cached public ledger.

Federal contracts

NUS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for NUS in this window.
Lobbying spend

NUS lobbying filings, year to date.

Registered lobbying filings matched to NuSkin Enterprises, Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for NUS in this window.
Loading news for NUS
Analyst ratings
Sovereign unlock shows live analyst consensus for NUS.
Options
Sovereign unlock shows live options positioning for NUS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.